Cytoreductive radiotherapy combined with abiraterone in metastatic castration-resistance prostate cancer: a single center experience
Abstract Background To investigate the potential benefit of cytoreductive radiotherapy (cRT) in metastatic castration-resistant prostate cancer (mCRPC) patients receiving abiraterone. Methods From February 2014 to February 2019, 149 mCRPC patients treated with abiraterone were identified. Patients r...
Zapisane w:
| Główni autorzy: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BMC
2021-01-01
|
| Seria: | Radiation Oncology |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1186/s13014-020-01732-y |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|